CRISPR

CRISPR1-hspa13

ID
ZDB-CRISPR-180703-3
Name
CRISPR1-hspa13
Previous Names
  • Z001432 (1)
Target
Sequence
5' - GGGTCATTGGGCTGGATCTT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
hg78 hspa13
hg79 hspa13
Expression
Gene expression in Wild Types + CRISPR1-hspa13
No data available
Phenotype
Phenotype resulting from CRISPR1-hspa13
No data available
Phenotype of all Fish created by or utilizing CRISPR1-hspa13
Phenotype Fish Conditions Figures
posterior lateral line neuromast has fewer parts of type neuromast hair cell, abnormal hspa13hg78/hg78 chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell Fig. 3 with image from Pei et al., 2018
swim bladder uninflated, abnormal hspa13hg78/hg78 standard conditions Fig. 2 with image from Pei et al., 2018
neuromast hair cell regeneration disrupted, abnormal hspa13hg78/hg78 chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell Fig. 3 with image from Pei et al., 2018
ventral fin fold regeneration disrupted, abnormal hspa13hg78/hg78 amputation: ventral fin fold Fig. 4 with image from Pei et al., 2018
swim bladder uninflated, abnormal hspa13hg79/hg79 standard conditions Fig. 2 with image from Pei et al., 2018
neuromast hair cell regeneration disrupted, abnormal hspa13hg79/hg79 chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell Fig. 3 with image from Pei et al., 2018
ventral fin fold regeneration disrupted, abnormal hspa13hg79/hg79 amputation: ventral fin fold Fig. 4 with image from Pei et al., 2018
posterior lateral line neuromast has fewer parts of type neuromast hair cell, abnormal hspa13hg79/hg79 chemical treatment by environment: copper(II) sulfate, chemical ablation: neuromast hair cell Fig. 3 with image from Pei et al., 2018
liver regeneration disrupted, abnormal hspa13hg78/hg78; s931Tg/+ chemical ablation: liver, chemical treatment: metronidazole Fig. 5 with image from Pei et al., 2018
liver decreased size, abnormal hspa13hg78/hg78; s931Tg/+ chemical ablation: liver, chemical treatment: metronidazole Fig. 5 with image from Pei et al., 2018
liver regeneration disrupted, abnormal hspa13hg79/hg79; s931Tg/+ chemical ablation: liver, chemical treatment: metronidazole Fig. 5 with image from Pei et al., 2018
liver decreased size, abnormal hspa13hg79/hg79; s931Tg/+ chemical ablation: liver, chemical treatment: metronidazole Fig. 5 with image from Pei et al., 2018
Citations